Amicus Therapeutics, Inc. (FOLD) Financials

FOLD Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 777.9 million 617.7 million
2023-09-30 764.1 million 630.8 million
2023-06-30 730.1 million 618.5 million
2023-03-31 700.5 million 597.9 million

FOLD Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 1.7 million 18.1 million
2023-09-30 -39.9 million 16.5 million
2023-06-30 -18.3 million 16.6 million
2023-03-31 -20.0 million 34.9 million

FOLD Net Income

No data available :(

FOLD Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 286.2 million - 57.2 million
2023-09-30 280.3 million - 60.2 million
2023-06-30 265.6 million 393.4 million 58.8 million
2023-03-31 267.1 million 392.7 million 59.4 million

FOLD Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 293.6 million
2023-09-30 295.8 million
2023-06-30 292.8 million
2023-03-31 291.3 million

FOLD Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 1.7 million 35.0 million 70.2 million -
2023-09-30 1.6 million 40.7 million 65.7 million -
2023-06-30 2.2 million 35.1 million 65.8 million -
2023-03-31 1.9 million 41.5 million 74.2 million -

FOLD Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 115.1 million 13.5 million
2023-09-30 103.5 million 9.9 million
2023-06-30 94.5 million 9.1 million
2023-03-31 86.3 million 6.9 million

FOLD

Price: $10.40

52 week price:
9.70
14.57

Earnings Per Share: -0.51 USD

P/E Ratio: -22

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Volume: 1.4 million

Ebitda: -271.1 million

Market Capitalization: 3.2 billion

Links: